down arrow

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK0000145638
HKD
8.61
-0.05 (-0.58%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
The United Laboratories International Holdings Ltd.
Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Grand Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Luye Pharma Group Ltd.
SSY Group Ltd.
China Traditional Chinese Medicine Holdings Co. Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd.
HUTCHMED (China) Ltd.
Keymed Biosciences, Inc.
Why is Beijing Tong Ren Tang Chinese Medicine Co., Ltd. ?
1
High Management Efficiency with a high ROE of 19.94%
2
Company has very low debt and has enough cash to service the debt requirements
3
Healthy long term growth as Net Sales has grown by an annual rate of 28.67% and Operating profit at 36.57%
4
Flat results in Dec 24
  • OPERATING CASH FLOW(Y) Lowest at HKD 366.1 MM
  • ROCE(HY) Lowest at 12.6%
  • DEBT-EQUITY RATIO (HY) Highest at -41.62 %
5
With ROE of 12.40%, it has a Attractive valuation with a 1.88 Price to Book Value
  • Over the past year, while the stock has generated a return of 1.41%, its profits have risen by 14.6% ; the PEG ratio of the company is 1
6
Underperformed the market in the last 1 year
  • The stock has generated a return of 1.41% in the last 1 year, much lower than market (Hang Seng Hong Kong) returns of 26.67%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Beijing Tong Ren Tang Chinese Medicine Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
28.67%
EBIT Growth (5y)
36.57%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.35
Tax Ratio
17.26%
Dividend Payout Ratio
58.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
86.34%
ROE (avg)
19.94%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.88
EV to EBIT
9.91
EV to EBITDA
9.81
EV to Capital Employed
2.55
EV to Sales
4.66
PEG Ratio
1.04
Dividend Yield
0.05%
ROCE (Latest)
25.75%
ROE (Latest)
12.40%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Net Sales
At HKD 947.13 MM has Grown at 33%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Dividend per share
Highest at HKD 3.4
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (HKD)

Dividend Payout Ratio
Highest at 104.45%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by 0.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 45.21 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Operating Cash Flow
Lowest at HKD 366.1 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Operating Profit Margin
Lowest at 38.19 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio
Highest at -41.62 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."